FDA greenlights first clinical trials of Elon Musk’s human brain implants

Neuralink, Elon Musk’s neurotechnology company, recently obtained approval from the Food and Drug Administration (FDA) to conduct a clinical study of brain implants in humans. This marks the first in-human clinical study for the company.